37 related articles for article (PubMed ID: 4611434)
1. Medicinal grade opium tincture for severe diarrhea: effect revisited in observational study.
Dahlgren D; Hellström PM
Curr Opin Gastroenterol; 2024 May; 40(3):196-202. PubMed ID: 37903075
[TBL] [Abstract][Full Text] [Related]
2. Prevention and management of chemotherapy-induced diarrhea in patients with colorectal cancer: a consensus statement by the Canadian Working Group on Chemotherapy-Induced Diarrhea.
Maroun JA; Anthony LB; Blais N; Burkes R; Dowden SD; Dranitsaris G; Samson B; Shah A; Thirlwell MP; Vincent MD; Wong R
Curr Oncol; 2007 Feb; 14(1):13-20. PubMed ID: 17576459
[TBL] [Abstract][Full Text] [Related]
3. Loperamide: a review of its pharmacological properties and therapeutic efficacy in diarrhoea.
Heel RC; Brogden RN; Speight TM; Avery GS
Drugs; 1978 Jan; 15(1):33-52. PubMed ID: 342229
[TBL] [Abstract][Full Text] [Related]
4. Effect of loperamide on fecal output and composition in well-established ileostomy and ileorectal anastomosis.
Tytgat GN; Huibregtse K; Dagevos J; van den Ende A
Am J Dig Dis; 1977 Aug; 22(8):669-76. PubMed ID: 327797
[No Abstract] [Full Text] [Related]
5. Double-blind placebo-controlled study of loperamide (Imodium) in chronic diarrhoea caused by ileocolic disease or resection.
Mainguet P; Fiasse R
Gut; 1977 Jul; 18(7):575-9. PubMed ID: 326642
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of loperamide.
Ericsson CD; Johnson PC
Am J Med; 1990 Jun; 88(6A):10S-14S. PubMed ID: 2192552
[TBL] [Abstract][Full Text] [Related]
7. Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 7: Clinical investigation. Efficacy and safety of loperamide in patients with severe chronic diarrhea.
Verhaegen H; De Cree J; Schuermans V
Arzneimittelforschung; 1974 Oct; 24(10):1657-60. PubMed ID: 4611433
[No Abstract] [Full Text] [Related]
8. Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 6: Clinical pharmacology. Placebo-controlled comparison of the constipating activity and safety of loperamide, diphenoxylate and codeine in normal volunteers.
Schuermans V; Van Lommel R; Dom J; Brugmans J
Arzneimittelforschung; 1974 Oct; 24(10):1653-7. PubMed ID: 4611432
[No Abstract] [Full Text] [Related]
9. Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 1: in vivo oral pharmacology and acute toxicity. Comparison with morphine, codeine, diphenoxylate and difenoxine.
Niemegeers CJ; Lenaerts FM; Janssen PA
Arzneimittelforschung; 1974 Oct; 24(10):1633-6. PubMed ID: 4479775
[No Abstract] [Full Text] [Related]
10. A double blind crossover comparison of loperamide with diphenoxylate in the symptomatic treatment of chronic diarrhea.
Pelemans W; Vantrappen F
Gastroenterology; 1976 Jun; 70(6):1030-4. PubMed ID: 773736
[TBL] [Abstract][Full Text] [Related]
11. A multicentre double-blind study in acute diarrhoea comparing loperamide (R 18553) with two common antidiarrhoeal agents and a placebo.
Amery W; Duyck F; Polak J; van den Bouwhuysen G
Curr Ther Res Clin Exp; 1975 Mar; 17(3):263-70. PubMed ID: 123844
[No Abstract] [Full Text] [Related]
12. Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 8: Clinical investigation. Use of a flexible dosage schedule in a double-blind comparison of loperamide with diphenoxylate in 614 patients suffering from acute diarrhea.
Dom J; Leyman R; Schuermans V; Brugmans J
Arzneimittelforschung; 1974 Oct; 24(10):1660-5. PubMed ID: 4611434
[No Abstract] [Full Text] [Related]
13. The role of loperamide in gastrointestinal disorders.
Hanauer SB
Rev Gastroenterol Disord; 2008; 8(1):15-20. PubMed ID: 18477966
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
